Axsome Therapeutics Inc

Healthcare · Biotechnology

196.00$ +1.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Axsome Therapeutics Inc (AXSM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 761 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AXSM
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	601	588	546	548	561	568	597	640	669	690	714	761
Current Assets	512	504	460	463	479	485	495	537	565	589	611	657
Cash	417	386	331	316	327	315	301	303	325	323	305	320
Cash & Short-Term Investments	417	386	331	316	327	315	301	303	325	323	305	320
Receivables	78	95	101	120	124	142	161	199	197	224	251	277
Inventory	10.0	15	16	15	14	16	16	18	24	28	32	38
Property, Plant & Equipment	8.0	–	–	–	–	–	–	–	–	–	–	–
Goodwill	12	12	12	12	12	12	12	12	12	12	12	12
Intangible Assets	55	53	52	50	49	47	45	44	42	41	39	37
Total Liabilities	331	397	402	445	469	511	543	567	596	602	659	678
Current Liabilities	115	139	144	187	196	230	244	342	360	379	439	460
Short-Term Debt	0.4	1.3	1.8	2.6	2.9	3.3	2.3	72	73	73	74	71
Accounts Payable	29	41	54	61	64	72	86	92	54	66	107	79
Long-Term Debt	177	178	179	179	180	181	181	118	118	118	118	118
Shareholders' Equity	270	191	144	103	93	57	53	73	74	88	55	83
Retained Earnings	-737	-836	-904	-983	-1,048	-1,123	-1,182	-1,230	-1,277	-1,306	-1,371	-1,422
Shares Outstanding	47	47	47	48	48	49	49	49	50	51	51	52

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings